BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12134783)

  • 1. [Can a hydergine therapy lead to damage of the coronary vessels?].
    Müller FU
    Dtsch Med Wochenschr; 2002 Jun; 127(25-26):1401. PubMed ID: 12134783
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of catecholamines on the resistance and capacity of the coronary vessels].
    Ovsiannikov VI
    Vestn Akad Med Nauk SSSR; 1973; 28(12):10-4. PubMed ID: 4150721
    [No Abstract]   [Full Text] [Related]  

  • 3. [10 years' experience of using Hydergine in a gynaecological and obstetric unit].
    Barrier G
    Rev Fr Gynecol Obstet; 1973 Nov; 68(11):687-9. PubMed ID: 17474227
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs to treat Alzheimer's disease.
    J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):13-4. PubMed ID: 19437925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on prevention of thromboembolism using panthesin-hydergin].
    Schwalbe E; Fauner A
    Med Monatsschr; 1971 Apr; 25(4):185-8. PubMed ID: 4995458
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of sympatholytics (hydergine) in association with other drugs in the prevention and treatment of post-operative acute renal insufficiency].
    Morra A; Pettinelli U
    Minerva Chir; 1970 Dec; 25(23):1600-6. PubMed ID: 4994489
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs to treat Alzheimer's disease.
    J Psychosoc Nurs Ment Health Serv; 2013 Apr; 51(4):11-2. PubMed ID: 23565878
    [No Abstract]   [Full Text] [Related]  

  • 8. [New data on Hydergine action in arterial pathology of the limbs. Critical study using angiography and liquid crystals].
    Bourde C; Ambrosi C
    Therapie; 1972; 27(6):1091-106. PubMed ID: 4197717
    [No Abstract]   [Full Text] [Related]  

  • 9. Utilization of thioridazine combined with hydergine in the treatment of incipient mental disturbances in cerebral atherosclerosis.
    Predescu V; Ciurezu T; Nica S; Ionescu R; Tudorache D; Niţurad A; Oproiu L; Popovici I; Curelaru S; Roman I
    Rev Roum Neurol Psychiatr; 1974; 11(3):243-8. PubMed ID: 4211107
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacology of coronary dilators].
    Hashimoto K
    Saishin Igaku; 1970 Jan; 25(1):120-5. PubMed ID: 5445204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interpretation of the clinical signs in the light of recent acquisitions].
    Heyck H
    Minerva Med; 1968 Dec; 59(96):5200-6. PubMed ID: 4974812
    [No Abstract]   [Full Text] [Related]  

  • 13. [The place of a peripheral vasodilator agent in the treatment of shock states].
    Lareng L; Jorda MF; Cathala B; Mathelin D
    Anesth Analg (Paris); 1974; 31(1):41-51. PubMed ID: 4210208
    [No Abstract]   [Full Text] [Related]  

  • 14. Ischaemic ulcers of the lower limb. A comparison of general and local methods of treatment.
    Haeger K
    Acta Chir Scand; 1965 Dec; 130(6):584-92. PubMed ID: 4955989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute stress and pulmonary edema].
    Metz G; Spiess B; Classen HG; Mittermayer C; Vogel W
    Arzneimittelforschung; 1974 Oct; 24(10):1625-7. PubMed ID: 4154762
    [No Abstract]   [Full Text] [Related]  

  • 16. Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency.
    Rehman SA
    Curr Med Res Opin; 1973; 1(8):456-62. PubMed ID: 4204089
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on treatment with nicergoline in a group of patients with hemiplegia in a post-acute phase].
    Zucconi V; Bolaffio MT
    Minerva Med; 1974 Mar; 65(17):936-45. PubMed ID: 4151126
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydergine, a vasodilator; clinical report on hydergine in peripheral vascular disease.
    STICK WD
    Pa Med J; 1956 Sep; 59(9):1072-4. PubMed ID: 13359090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of catecholamines on the resistance and capacity of coronary vessels before and after blockade of their adrenoreceptors].
    Ovsiannikov VI
    Fiziol Zh SSSR Im I M Sechenova; 1972 Sep; 58(9):1415-24. PubMed ID: 4628689
    [No Abstract]   [Full Text] [Related]  

  • 20. [Eutergine and retinal arteriosclerosis].
    Ourgaud AG; Metge P; Cazenave P
    Bull Soc Ophtalmol Fr; 1975; 75(5-6):591-607. PubMed ID: 813835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.